- Home
- WAVE vs CASI Comparison
WAVE vs CASI Comparison
Compare WAVE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- CASI
- Stock Information
- Founded
- WAVE 2011
- CASI 1991
- Country
- WAVE Israel
- CASI China
- Employees
- WAVE N/A
- CASI N/A
- Industry
- WAVE Electric Utilities: Central
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- CASI Health Care
- Exchange
- WAVE Nasdaq
- CASI Nasdaq
- Market Cap
- WAVE 34.2M
- CASI 29.0M
- IPO Year
- WAVE 2021
- CASI 1996
- Fundamental
- Price
- WAVE $5.56
- CASI $1.27
- Analyst Decision
- WAVE Strong Buy
- CASI Strong Buy
- Analyst Count
- WAVE 1
- CASI 1
- Target Price
- WAVE $15.00
- CASI $4.00
- AVG Volume (30 Days)
- WAVE 17.1K
- CASI 295.8K
- Earning Date
- WAVE 05-08-2025
- CASI 08-15-2025
- Dividend Yield
- WAVE N/A
- CASI N/A
- EPS Growth
- WAVE N/A
- CASI N/A
- EPS
- WAVE N/A
- CASI N/A
- Revenue
- WAVE $168,000.00
- CASI $31,368,000.00
- Revenue This Year
- WAVE $325.00
- CASI N/A
- Revenue Next Year
- WAVE $85.71
- CASI N/A
- P/E Ratio
- WAVE N/A
- CASI N/A
- Revenue Growth
- WAVE N/A
- CASI 8.39
- 52 Week Low
- WAVE $2.37
- CASI $1.10
- 52 Week High
- WAVE $17.63
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- WAVE 48.66
- CASI 32.05
- Support Level
- WAVE $4.41
- CASI $1.22
- Resistance Level
- WAVE $6.00
- CASI $1.42
- Average True Range (ATR)
- WAVE 0.43
- CASI 0.28
- MACD
- WAVE 0.01
- CASI -0.04
- Stochastic Oscillator
- WAVE 72.70
- CASI 10.44
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.